Trial · NCT06291831
Outcomes17
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
1 to 17 of 17
Download this page as JSON| Type | Outcome | Time frame | Population | Units | Measured as |
|---|---|---|---|---|---|
| PRIMARY | Number of Participants Classified Based on Education | Baseline; from available retrospective data evaluated during 2 months of this study | I-Seha EHR was used to retrieve the data in this study for evaluation of its objectives. Education information required for this outcome measure was not available in I-Seha EHR. Hence, there was no data that could be analyzed for this outcome measure. | ||
| PRIMARY | Number of Participants Classified Based on Employment Status | Baseline; from available retrospective data evaluated during 2 months of this study | I-Seha EHR was used to retrieve the data in this study for evaluation of its objectives. Employment status information required for this outcome measure was not available in I-Seha EHR. Hence, there was no data that could be analyzed for this outcome measure. | ||
| PRIMARY | Height | Baseline; from available retrospective data evaluated during 2 months of this study | I-Seha EHR was used to retrieve the data in this study for evaluation of its objectives. Height information required for this outcome measure was not available in I-Seha EHR. Hence, there was no data that could be analyzed for this outcome measure. | ||
| PRIMARY | Weight | Baseline; from available retrospective data evaluated during 2 months of this study | I-Seha EHR was used to retrieve the data in this study for evaluation of its objectives. Weight information required for this outcome measure was not available in I-Seha EHR. Hence, there was no data that could be analyzed for this outcome measure. | ||
| PRIMARY | Body Mass Index (BMI) | Baseline; from available retrospective data evaluated during 2 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. BMI was extracted from records and method how it was collected originally was not known. | Kilogram over meter square (Kg/m^2) | MEDIAN |
| PRIMARY | Number of Participants Classified Based on Smoking Status | Baseline; from available retrospective data evaluated during 2 months of this study | I-Seha EHR was used to retrieve the data in this study for evaluation of its objectives. Smoking status information required for this outcome measure was not available in I-Seha EHR. Hence, there was no data that could be analyzed for this outcome measure. | ||
| PRIMARY | Number of Participants With at Least 1 Pre-existing Comorbidities | Baseline; from available retrospective data evaluated during 2 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. | Participants | COUNT_OF_PARTICIPANTS |
| PRIMARY | Number of Participants Who Took at Least 1 Concomitant Medications for Pre-existing Comorbidities | Baseline; from available retrospective data evaluated during 2 months of this study | I-Seha EHR was used to retrieve the data in this study for evaluation of its objectives. Concomitant medications for pre-existing comorbidities information required for this outcome measure was not available in I-Seha EHR. Hence, there was no data that could be analyzed for this outcome measure. | ||
| PRIMARY | Number of Participants Who Used Antibiotics | Up to 24 months following COVID-19 diagnosis; from available retrospective data evaluated during 2 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With Hospitalization for Any Cause | Up to 24 months following COVID-19 diagnosis; from available retrospective data evaluated during 2 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With Intensive Care Unit (ICU) Admission for Any Cause | Up to 24 months following COVID-19 diagnosis; from available retrospective data evaluated during 2 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants Classified According to Length of Stay (LOS) in ICU for Any Cause | Up to 24 months following COVID-19 diagnosis; from available retrospective data evaluated during 2 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. Here Overall Number of Participants Analyzed signifies the number of participants evaluable for this outcome measure. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With Yes/no Questionnaire on Outpatient Visits | Up to 24 months following COVID-19 diagnosis; from available retrospective data evaluated during 2 months of this study | I-Seha EHR was used to retrieve the data in this study for evaluation of its objectives. Participants with yes/no questionnaire on outpatient visits information required for this outcome measure was not available in I-Seha EHR. Hence, there was no data that could be analyzed for this outcome measure. | ||
| SECONDARY | Number of Participants With Emergency Room (ER) Visits for Any Cause | Up to 24 months following COVID-19 diagnosis; from available retrospective data evaluated during 2 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With Supplemental Oxygen Usage | Up to 24 months following COVID-19 diagnosis; from available retrospective data evaluated during 2 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. | Participants | COUNT_OF_PARTICIPANTS |
| SECONDARY | Number of Participants With Vasopressor Use | Up to 24 months following COVID-19 diagnosis; from available retrospective data evaluated during 2 months of this study | I-Seha EHR was used to retrieve the data in this study for evaluation of its objectives. Participants with vasopressor use information required for this outcome measure was not available in I-Seha EHR. Hence, there was no data that could be analyzed for this outcome measure. | ||
| SECONDARY | Number of Participants Who Used Invasive Mechanical Ventilation (IMV) | Up to 24 months following COVID-19 diagnosis; from available retrospective data evaluated during 2 months of this study | Analysis population included all eligible participants whose data were included and observed in this study. | Participants | COUNT_OF_PARTICIPANTS |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT06291831/outcomes